Stock of Tempus AI, Inc. (TEM) is climbing about 9 percent on Wednesday morning trading after the company, along with Predicta Biosciences, announced the commercial expansion of a co-branded whole-genome sequencing assay, currently known as GenoPredicta.
The company's shares are currently trading at $54.30 on the Nasdaq, up 9.74 percent. The stock opened at $50.35 and has climbed as high as $54.91 so far in today's session. Over the past year, it has traded in a range of $39.01 to $104.32.
GenoPredicta intended for the comprehensive genomic characterization of hematologic malignancies and measurable residual disease monitoring.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.